NCT05309070View on ClinicalTrials.gov

The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Burning Mouth Syndrome
Interventions
DIETARY_SUPPLEMENT

N-acetyl cysteine

Study group will receive N-acetyl cysteine in unmarked boxes, in a daily dose of 1200 mg during two months

OTHER

placebo

Control group will receive a placebo, in unmarked boxes, during two months

Trial Locations (1)

10000

School of Dental Medicine, University of Zagreb, Zagreb

All Listed Sponsors
lead

University of Zagreb

OTHER